Comparison of the efficacy of subcutaneous and sublingual immunotherapy in mite-sensitive patients with rhinitis and asthma—a placebo controlled study

BSACI Working Party on Allergen Immunotherapy, 1993, Position paper, Clin Exp Allergy, 23, 32

Stewart, 1992, Systemic reactions from allergen immunotherapy, J Allergy Clin Immunol, 90, 567, 10.1016/0091-6749(92)90129-P

Tamir, 1992, Immediate adverse reactions to immunotherapy in allergy, Allergy, 47, 260, 10.1111/j.1398-9995.1992.tb00660.x

Passalacqua, 1996, Alternative routes for allergen-specific immunotherapy, J Invest Allergol Clin Immunol, 6, 81

1994, International Consensus Report on Diagnosis and Management of Rhinitis, Allergy, 19, 13

1995, AAAAI and ACAAI Practice parameters for the diagnosis and treatment of asthma, J Allergy Clin Immunol, 96, 809

International Consensus Report on Diagnosis and Treatment of Asthma, 1992, National Heart, Lung and Blood Institute, Publication No. 92–3091, Eur Respir J, 5, 601

Tari, 1990, Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A double blind study, Allergol Immunopathol, 18, 277

Cockcroft, 1991, Airway hyperresponsiveness: definition, measurement and clinical relevance, 51

Sabbah, 1994, A double blind placebo controlled trial by the sublingual route of immunotherapy with a standardized grass pollen extract, Allergy, 49, 309, 10.1111/j.1398-9995.1994.tb02273.x

Malling, 1994, Immunotherapy in Europe, Clin Exp Allergy, 24, 515, 10.1111/j.1365-2222.1994.tb00948.x

Malling, 1993, Immunotherapy EAACI Position Papers, Allergy, 48, 9, 10.1111/j.1398-9995.1993.tb04754.x

Platts-Mills, 1993, Allergen specific treatment for asthma: III, Am Rev Respir Dis, 143, 553, 10.1164/ajrccm/148.3.553

Feliziani, 1993, Rush immunotherapy with sublingual administration of grass allergen extract, Allergol Immunopathol, 21, 173

Tari, 1994, Immunologic evaluation of 24 month course of sublingual immunotherapy, Allergol Immunopathol, 22, 209

Troise, 1995, Sublingual immunotherapy in parietaria pollen induced rhinitis: a double blind study, J Invest Allergol Clin Immunol, 5, 25

Nelson, 1993, A double blind placebo controlled evaluation of sublingual immunotherapy with standardized cat extract, J Allergy Clin Immunol, 92, 229, 10.1016/0091-6749(93)90166-D

Piazza, 1993, Humoral response to subcutaneous, oral and nasal immunotherapy for allergic rhinitis due to dermatophagoides pteronyssinus, Ann Allergy, 71, 461

Bousquet, 1994, Specific immunotherapy in asthma: Is it effective?, J Allergy Clin Immunol, 94, 1, 10.1016/0091-6749(94)90064-7

Haugaard, 1993, A controlled dose response study of immunotherapy with standardized, partially purified extract of house dust mite: clinical efficacy and side effects, J Allergy Clin Immunol, 91, 709, 10.1016/0091-6749(93)90190-Q

Murray, 1985, Non allergic bronchial hyperreactivity in asthmatic children decreases with age and increases with mite immunotherapy, Ann Allergy, 54, 541

Foresi, 1992, Bronchial inflammation in mite sensitive asthmatic subjects after 5 years of specific immunotherapy, Ann Allergy, 69, 303

Van Metre, 1993, Immunotherapy for aeroallergen disease, 1489

Bousquet, 1985, Immunotherapy with a standardized dermatophagoides pteronyssinus extract. In vivo and in vitro parameters after a short course of treatment, J Allergy Clin Immunol, 76, 734, 10.1016/0091-6749(85)90680-3

Bousquet, 1988, Specific immunotherapy with a standardized dermatophagoides pteronyssinus extract, J Allergy Clin Immunol, 82, 971, 10.1016/0091-6749(88)90133-9

Aalberse, 1993, Allergen specific IgG4 in atopic disease, Allergy, 48, 559, 10.1111/j.1398-9995.1993.tb00749.x

Igea, 1994, Susceptibility of a grass pollen oral immunotherapy extract to the saliva and gastric fluid digestive process, Allergol Immunopathol, 22, 55